Nordic showing latest Optibodies® and lab services at Region Skåne conference


Nordic showing latest Optibodies® and lab services at Region Skåne conference


Nordic Biosite Logo

Press Release | Nordic Biosite AB

OCTOBER 13, 2016

Täby, Sweden: – Scandinavia’s leading supplier of validated biotechnology products, Nordic BioSite, will be a prominent presence at the Skane Regional meeting for Clinical Pathology, Regionmötet 2016, in southern Sweden.

Nordic BioSite has its own exhibition stand at the meeting venue, the Hotel Marina Plaza in Helsingborg, where a team led by Joacim Nilsson, Product Specialist for IHC/FLOW, will showcase the company’s Optibodies® range of optimized antibodies, along with its Laboratory Services.

RNA purification offers

“We will be able to show particularly interesting developments on our Optibodies range of highly validated antibodies for immunohistochemistry, as well as significant new reagent products for RNA purification,” said Mr. Nilsson.

The Nordic BioSite team will also have special event-only offers for researchers interested in testing purification products.

Clinical pathology

“We regularly attend Regionmötet Skåne since the Skane Region of southern Sweden is a significant market for our pathology and clinical diagnostic products and lab services. This meeting presents a great opportunity to meet end users and potential partners,” said Mr. Nilsson.

“We look forward to talking to clinical pathology, cytology and clinical Immunology professionals looking for high quality and long-term effective products and responsive local service,” he added.

About Nordic BioSite

Since the late 1990s, Nordic BioSite has become recognized as one of the pharma industry’s most innovative and customer-responsive supplier of high quality validated biotechnology products for research, diagnostics, immunology and molecular biology.

The company serves pharmaceutical, biotech, diagnostic and academic organizations with tens of thousands of different products in more than 30 different groups, ranging from antibodies to genetic vectors. These are sourced from selected manufacturers and laboratories in Europe, the Americas and Asia.

Nordic BioSite continuously introduces new products as a result of its own R&D, leveraged by close partnerships with manufacturers and feedback from customers.

Nordic BioSite’s company strapline, By Your Side™, defines a company ethos of partnering life science customers h, helping to find the right products and services to help reach chosen goals across the whole spectrum of biotech research areas.

Nordic BioSite also operates as a CRO through its Finnish-based cGLP laboratory, BioSiteHisto. This offers a wide range of leading-edge research-based custom laboratory services including histology, immunochemistry, in vitro research and testing, antibody optimization, antibody conjugation and predesigned adenylated linkers for Next Generation Sequencing (NGS).

About Regionmötet 2016

The Region Skåne Meeting for Clinical Pathology, Regionmötet 2016, is an annual conference hosted by Caregivers Skane, the regional healthcare authority for the area around Kristianstad and Malmö in southern Sweden.

Regionmötet 2016 is a two-day event opening October 13 at the Hotel Marina Plaza in Helsingborg.

This year’s meeting will focus on urology, with discussions on bladder and prostate cancers, as well as on molecular diagnostics and also features an exhibition and networking events.

The event is organized by the Region Skåne Healthcare Council, with more information available at: http://vardgivare.skane.se/siteassets/1

Media Contact

Yvonne Zar, Communications Director, Nordic BioSite AB
Tel: +46 (0) 854 443 340
Email: info@nordicbiosite.com

Resources

Click on Nordic showing latest Optibodies® and lab services at Region Skåne conference for more information.
Click on Nordic Biosite to contact the company directly.


Supplier Information
Supplier: Nordic Biosite
Address: Propellervägen 4A, 183 62 Täby, Sweden
Tel: +46 (0)8 544 433 40
Fax: +46 (0)8 756 94 90
Website: www.nordicbiosite.com


Comments are closed.